|
US7731972B1
(en)
*
|
2000-02-04 |
2010-06-08 |
Vlaams Interuniversitair Instituut Voor Biotechnologie |
Immunoprotective influenza antigen and its use in vaccination
|
|
WO1999022763A2
(en)
*
|
1997-10-31 |
1999-05-14 |
Cistron Biotechnology, Inc. |
Encapsulated immunomodulators useful as vaccine adjuvants
|
|
AT407958B
(de)
*
|
1999-02-11 |
2001-07-25 |
Immuno Ag |
Inaktivierte influenza-virus-vakzine zur nasalen oder oralen applikation
|
|
DE60117164T2
(de)
*
|
2000-11-07 |
2006-08-03 |
Immuno Vaccine Technologies Inc., Halifax |
Impfstoffe mit erhöhter immunantwort und verfahren zur deren herstellung
|
|
AU3652602A
(en)
*
|
2000-11-15 |
2002-05-27 |
Us Gov Health & Human Serv |
Sol-fusin: use of gp64-6his to catalyze membrane fusion
|
|
MY134424A
(en)
*
|
2001-05-30 |
2007-12-31 |
Saechsisches Serumwerk |
Stable influenza virus preparations with low or no amount of thiomersal
|
|
US20060029655A1
(en)
*
|
2001-06-25 |
2006-02-09 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Method for preparation of vesicles loaded with biological material and different uses thereof
|
|
WO2003004054A1
(en)
*
|
2001-07-05 |
2003-01-16 |
Virocell Inc. |
Ltb4 as vaccine aduvant
|
|
US20040247661A1
(en)
*
|
2002-07-03 |
2004-12-09 |
Dov Michaeli |
Liposomal vaccine
|
|
CN1665487A
(zh)
*
|
2002-07-03 |
2005-09-07 |
埃弗顿有限公司 |
脂质体疫苗
|
|
US20050169979A1
(en)
*
|
2002-07-03 |
2005-08-04 |
Dov Michaeli |
Liposomal vaccine
|
|
KR20060015534A
(ko)
|
2003-04-25 |
2006-02-17 |
더 펜 스테이트 리서치 파운데이션 |
성장 억제, 지질 유래된 생활성 화합물의 전신 전달을 위한방법 및 시스템
|
|
WO2004100928A1
(de)
*
|
2003-05-09 |
2004-11-25 |
Novosom Ag |
Injizierbare liposomale depots zum wirkstoffdelivery
|
|
AU2004263037B2
(en)
*
|
2003-08-11 |
2011-02-10 |
Japan As Represented By The Director-General Of National Institute Of Infectious Diseases |
Novel vaccine containing adjuvant capable of inducing mucosal immunity
|
|
WO2005018610A1
(en)
*
|
2003-08-21 |
2005-03-03 |
Lipotek Pty Ltd |
In vivo targeting of dendritic cells
|
|
FR2868951B1
(fr)
*
|
2004-04-15 |
2006-07-21 |
Ethypharm Sa |
Compositions contenant ds vesicules lamellaires incorporant un principe actif peu soluble dans l'eau et produits intermediaires utiles pour leur preparation
|
|
US20050260260A1
(en)
*
|
2004-05-19 |
2005-11-24 |
Edward Kisak |
Liposome compositions for the delivery of macromolecules
|
|
WO2006074303A2
(en)
*
|
2005-01-05 |
2006-07-13 |
Philadelphia Health And Education Corporation |
Delivery vehicles, bioactive substances and viral vaccines
|
|
CA2523032A1
(en)
|
2005-10-07 |
2007-04-07 |
Immunovaccine Technologies Inc. |
Vaccines for cancer therapy
|
|
ES2588705T3
(es)
*
|
2007-09-27 |
2016-11-04 |
Immunovaccine Technologies Inc. |
Uso de liposomas en un vehículo que comprende una fase hidrófoba continua para la entrega de polinucleótidos in vivo
|
|
US20100209452A1
(en)
*
|
2007-10-03 |
2010-08-19 |
Immunovaccine Technologies, Inc |
Compositions comprising an antigen, an amphipathic compound and a hydrophobic carrier, and uses thereof
|
|
EP2231180B1
(en)
*
|
2008-01-16 |
2016-08-17 |
Ben-gurion University Of The Negev Research And Development Authority |
Vaccine for alzheimer's disease
|
|
CA2723918C
(en)
|
2008-06-05 |
2018-01-09 |
Immunovaccine Technologies Inc. |
Compositions comprising liposomes, an antigen, a polynucleotide and a carrier comprising a continuous phase of a hydrophobic substance
|
|
EP2299953B1
(en)
*
|
2008-07-14 |
2017-04-12 |
Polypid Ltd. |
Sustained-release drug carrier composition
|
|
US20120157419A1
(en)
|
2009-02-02 |
2012-06-21 |
Tuvia Gilat |
Methods and compositions for treating alzheimer's disease
|
|
MX2012000372A
(es)
|
2009-07-06 |
2012-02-28 |
Variation Biotechnologies Inc |
Metodos para preparar vesiculas y formulaciones producidas a partir de las mismas.
|
|
US9907746B2
(en)
|
2009-07-06 |
2018-03-06 |
Variation Biotechnologies, Inc. |
Methods for preparing vesicles and formulations produced therefrom
|
|
CN102470105B
(zh)
|
2009-07-14 |
2015-07-29 |
波利皮得有限公司 |
持续释放药物载体组合物
|
|
EP2485758A1
(en)
|
2009-10-09 |
2012-08-15 |
New York Blood Center, Inc. |
Immunopotentiator-linked oligomeric influenza immunogenic compositions
|
|
JP5860409B2
(ja)
|
2010-01-19 |
2016-02-16 |
ポリピッド リミテッド |
徐放性核酸マトリックス組成物
|
|
CA2840079C
(en)
*
|
2010-07-06 |
2018-07-03 |
Variation Biotechnologies Inc. |
Compositions and methods for treating influenza
|
|
AU2012205315B2
(en)
|
2011-01-13 |
2017-05-04 |
Variation Biotechnologies, Inc. |
Methods for preparing vesicles and formulations produced therefrom
|
|
US10736844B2
(en)
|
2011-01-13 |
2020-08-11 |
Variation Biotechnologies Inc. |
Compositions and methods for treating viral infections
|
|
IN2014CN02581A
(enExample)
|
2011-10-06 |
2015-08-07 |
Immunovaccine Technologies Inc |
|
|
WO2013072768A2
(en)
|
2011-11-18 |
2013-05-23 |
Variation Biotechnologies, Inc. |
Synthetic derivatives of mpl and uses thereof
|
|
CA2894442C
(en)
|
2012-01-12 |
2020-01-21 |
Variation Biotechnologies Inc. |
Compositions and methods for treating viral infections
|
|
EP4008354A1
(en)
|
2012-01-27 |
2022-06-08 |
Variation Biotechnologies Inc. |
Methods and compositions for therapeutic agents
|
|
CN103736090B
(zh)
*
|
2014-01-27 |
2016-03-02 |
中国医学科学院医学生物学研究所 |
甲磺酸去铁胺佐剂及含甲磺酸去铁胺佐剂的疫苗
|
|
CN110151702A
(zh)
*
|
2019-06-24 |
2019-08-23 |
昆明医科大学 |
聚乙二醇修饰流感疫苗脂质体及其制备方法
|